Arctoris has been featured by Formic Ventures following the firm’s investment in the company. Formic Ventures is a venture capital firm focused on supporting biotechnology startups and innovations that can improve human health and longevity.
The investment reflects confidence in Arctoris’ automated drug discovery platform, which combines robotics, advanced data generation, and scientific expertise to accelerate the development of new therapeutics. By automating key experimental workflows, the platform enables researchers to generate high-quality biological data with improved speed, reproducibility, and scalability.
Formic Ventures highlighted how automated experimentation platforms can play an important role in modern drug discovery, particularly as artificial intelligence and computational approaches generate large numbers of hypotheses that require rapid experimental validation.
The announcement also references collaborations that combine Arctoris’ automated experimental capabilities with AI-driven drug discovery approaches. For example, partnerships with computational drug discovery companies can integrate AI-guided target identification and molecule design with high-throughput biological testing, accelerating the identification and validation of new drug candidates.
Through investments like this, Formic Ventures aims to support companies developing technologies that advance biomedical research and enable faster progress toward new therapies.
